Compare StocksABBV vs PODD

AbbVie Inc. (ABBV) vs Insulet Corporation (PODD): Which Is the Better Buy in 2026?

As of 2026-09-17, ABBV is overvalued at $263, with a DCF intrinsic value of $184 and a margin of safety of -43%. PODD is fairly valued at $139, with an intrinsic value of $137 and a margin of safety of -1%. Of the two, PODD has the wider margin of safety.

ABBV
AbbVie Inc.
$263.25
VS
PODD
Insulet Corporation
$139.09

Rewards

ABBV
  • AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • Gross margin of 72.8% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
PODD
  • Gross margin of 71.1% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Each dollar of retained earnings has created $3.09 of earning power — management is an exceptional capital allocator.
  • Trailing P/E of 26.1x is 98% below the historical average of 1100.9x — potentially undervalued relative to its own history.

Risks

ABBV
  • Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • Insiders have sold $8.2M worth of stock in the past 3 months — significant insider liquidation.
  • Free cash flow has declined at a 9.8% CAGR over the past 4 years — a concerning trend.
PODD

    Key Valuation Metrics

    Learn more →
    ABBV
    PODD
    Valuation
    $16.87B
    Free Cash Flow
    $349.90M
    3.63%
    FCF Yield
    3.63%
    74.36
    Trailing P/E
    26.09
    16.18
    Forward P/E
    18.04
    Quality & Moat
    28.73%
    ROIC
    16.46%
    N/A
    ROE
    26.02%
    72.79%
    Gross Margin
    71.08%
    0.54
    PEG Ratio
    1.11
    Balance Sheet Safety
    N/A
    Net Debt / Equity
    0.29
    N/A
    Interest Coverage
    N/A
    2.09
    Net Debt / EBITDA
    0.67
    2.64%
    Dividend Yield
    0.00%
    ABBV: 5Ties: 3PODD: 2
    ABBVPODD

    Historical Fundamentals

    Learn more →
    ABBV

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    PODD

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    $1 Retained Earnings Test

    Learn more →
    ABBV
    N/A
    Net losses over 3 years — test not applicable
    Company had negative cumulative retained earnings
    Σ Retained
    $-19.85B
    Δ Market Cap
    +$118.02B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
    PODD
    $-0.52
    created per $1 retained over 3 years
    Market Cap Declined
    Σ Retained
    $871.7M
    Δ Market Cap
    $-455.5M
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Discounted Cash Flow (DCF) Analysis

    Learn more →
    ABBV
    43.1% Overvalued
    Price is 43.1% above estimated fair value
    Current Price: $263.25
    Fair Value: $183.97
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued
    PODD
    1.3% Overvalued
    Price is 1.3% above estimated fair value
    Current Price: $139.09
    Fair Value: $137.29
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued

    Reverse DCF — Market-Implied Growth

    Learn more →
    ABBV

    What growth rate is the market pricing in at $263?

    +19.5%
    Market-Implied Owner Earnings Growth
    Standard FCF implies +13.8%

    The market implies +19.5% Owner Earnings growth, above historical trends.

    Standard FCF implies a demanding +13.8%, reflecting heavy growth investment.

    PODD

    What growth rate is the market pricing in at $139?

    +17.4%
    Market-Implied Owner Earnings Growth
    Standard FCF implies +12.7%

    The market implies +17.4% Owner Earnings growth, below historical trends — potential opportunity.

    Standard FCF implies a more demanding +12.7%, reflecting heavy growth investment expected to generate future returns.

    Economic Moat Score

    Learn more →
    ABBV
    82/100
    Wide Moat
    70+ Wide · 40-69 Narrow · <40 None

    Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
    PODD
    55/100
    Narrow Moat
    70+ Wide · 40-69 Narrow · <40 None

    Narrow moat with revenue predictability as the key competitive advantage. Improving roic consistency would strengthen the moat.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

    Forensic Accounting

    Learn more →
    ABBV
    -2.86
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
    PODD
    -2.51
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Ownership Breakdown

    Learn more →
    ABBV
    Insiders 0.1%Institutions 77.4%Retail & Other 22.5%
    No. of Institutional Holders5,262
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
    PODD
    Insiders 0.3%Institutions 107.1%
    No. of Institutional Holders1,099
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

    High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

    Insider Buying Activity

    Learn more →
    ABBV
    0
    Buys (3M)
    0
    Buys (12M)
    No open market insider purchases found.
    Open market purchases · includes direct & indirect ownership · excludes option exercises
    PODD
    0
    Buys (3M)
    4
    Buys (12M)
    Total value (12M): $1.70M
    WEATHERMAN ELIZABETH H
    Director
    $497,490
    @ $144.20 · 2026-06-03
    STONESIFER TIMOTHY C
    Director
    $400,393
    @ $143.51 · 2026-06-03
    MINOGUE MICHAEL R
    Director
    $499,847
    @ $246.23 · 2026-02-25
    STONESIFER TIMOTHY C
    Director
    $299,884
    @ $311.73 · 2025-12-05
    Open market purchases · includes direct & indirect ownership · excludes option exercises

    Open market purchases · includes direct & indirect ownership · excludes option exercises.

    Insider Selling Activity

    Learn more →
    ABBV
    1
    Sells (3M)
    4
    Sells (12M)
    Total value (12M): $18.92M
    DONOGHOE NICHOLAS
    Officer
    $8.18M
    @ $250.00 · 2026-08-14
    PURDUE DAVID RYAN
    Officer
    $1.22M
    @ $233.56 · 2026-03-04
    SIATIS PERRY C.
    General Counsel
    $4.38M
    @ $234.39 · 2026-03-02
    SIATIS PERRY C.
    General Counsel
    $5.15M
    @ $230.00 · 2026-02-25
    SALEKI-GERHARDT AZITA
    Chief Operating Officer
    $8.41M
    @ $198.42 · 2025-08-12
    DONOGHOE NICHOLAS
    Officer
    $2.64M
    @ $198.51 · 2025-08-05
    STEWART JEFFREY RYAN
    Officer
    $12.36M
    @ $210.08 · 2025-03-31
    REENTS SCOTT T.
    Chief Financial Officer
    $3.75M
    @ $212.34 · 2025-03-14
    RICHMOND TIMOTHY J
    Officer
    $4.47M
    @ $210.45 · 2025-03-03
    SIATIS PERRY C.
    General Counsel
    $5.82M
    @ $208.69 · 2025-03-03
    GONZALEZ RICHARD A
    Director
    $20.26M
    @ $205.45 · 2025-03-03
    RICHMOND TIMOTHY J
    Officer
    $6.07M
    @ $202.90 · 2025-02-26
    BUCKBEE KEVIN K
    Officer
    $3.85M
    @ $203.41 · 2025-02-26
    SIATIS PERRY C.
    General Counsel
    $1.14M
    @ $197.90 · 2025-02-20
    BUCKBEE KEVIN K
    Officer
    $310,032
    @ $172.24 · 2024-12-16
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
    PODD
    0
    Sells (3M)
    2
    Sells (12M)
    Total value (12M): $602,397
    BORIO LUCIANA
    Director
    $59,887
    @ $143.27 · 2026-06-03
    FREDERICK WAYNE A.I.
    Director
    $542,510
    @ $293.09 · 2025-12-15
    SINGH PREM
    Officer
    $238,726
    @ $347.49 · 2025-09-08
    COUSIN LAETITIA
    Officer
    $278,002
    @ $348.81 · 2025-09-08
    BENJAMIN ERIC
    Officer
    $1.42M
    @ $332.23 · 2025-08-21
    SINGH PREM
    Officer
    $429,760
    @ $320.00 · 2025-08-07
    SINGH PREM
    Officer
    $698,216
    @ $300.05 · 2025-06-13
    MANEA DANIEL
    Officer
    $390,065
    @ $300.05 · 2025-06-13
    BORIO LUCIANA
    Director
    $147,056
    @ $305.73 · 2025-06-09
    KAPPLES JOHN W.
    General Counsel
    $1.68M
    @ $318.47 · 2025-05-14
    HOPFIELD JESSICA
    Director
    $1.66M
    @ $317.54 · 2025-05-13
    BENJAMIN ERIC
    Officer
    $960,320
    @ $320.00 · 2025-05-13
    FREDERICK WAYNE A.I.
    Director
    $501,875
    @ $275.00 · 2025-03-25
    BENJAMIN ERIC
    Officer
    $3.47M
    @ $280.00 · 2025-01-21
    BENJAMIN ERIC
    Officer
    $1.17M
    @ $267.60 · 2024-12-16
    BUDDEN LAUREN
    Officer
    $252,192
    @ $275.62 · 2024-12-10
    BORIO LUCIANA
    Director
    $139,598
    @ $274.80 · 2024-11-12
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

    🎭 Mr. Market's Mood

    Learn more →
    ABBV
    FearGreed
    😏Greed(70/100)

    "Market is optimistic — be cautious and ensure you have a margin of safety"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
    PODD
    FearGreed
    😨Fear(30/100)

    "Market is pessimistic — investigate whether fears are temporary or structural"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    ⚖️ Buffett Signal

    Learn more →
    ABBV
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Greed (70)
    PODD
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Fear (30)
    View ABBV Full AnalysisView PODD Full Analysis

    Frequently Asked Questions: ABBV vs PODD

    Is AbbVie Inc. or Insulet Corporation more undervalued in 2026?

    Based on our discounted cash flow model, PODD trades at a -1.3% margin of safety (intrinsic value $137 vs. price $139), compared to ABBV's -43.1% margin of safety (intrinsic $184 vs. $263).

    Which stock has a wider economic moat, AbbVie Inc. or Insulet Corporation?

    ABBV scores 82/100 (Wide moat), while PODD scores 55/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

    Is AbbVie Inc. in financial distress?

    ABBV's Altman Z-Score of 2.4 places it in the Grey zone, signaling elevated bankruptcy risk. PODD scores 9.1 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

    Which company has better free cash flow, AbbVie Inc. or Insulet Corporation?

    Insulet Corporation (PODD) generates a 3.6% free cash flow yield, compared to AbbVie Inc.'s 3.6%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

    Which stock has higher return on invested capital, AbbVie Inc. or Insulet Corporation?

    ABBV earns 28.7% ROIC versus PODD's 16.5%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.